126 related articles for article (PubMed ID: 11207085)
21. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
22. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study.
Jain S; Gaiha M; Bhattacharjee J; Anuradha S
J Assoc Physicians India; 2002 Aug; 50():1028-33. PubMed ID: 12421024
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
Celik S; Doesch A; Erbel C; Blessing E; Ammon K; Koch A; Katus HA; Dengler TJ
Transplantation; 2008 Jul; 86(2):245-50. PubMed ID: 18645486
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
Andrés A; Morales E; Morales JM; Bosch I; Campo C; Ruilope LM;
Transplant Proc; 2006 Oct; 38(8):2419-23. PubMed ID: 17097955
[TBL] [Abstract][Full Text] [Related]
25. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
[TBL] [Abstract][Full Text] [Related]
26. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.
Nordøy A; Hansen JB; Brox J; Svensson B
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):7-16. PubMed ID: 11383326
[TBL] [Abstract][Full Text] [Related]
27. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
[TBL] [Abstract][Full Text] [Related]
28. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects.
Geelen A; Zock PL; Swenne CA; Brouwer IA; Schouten EG; Katan MB
Am Heart J; 2003 Aug; 146(2):E4. PubMed ID: 12891211
[TBL] [Abstract][Full Text] [Related]
29. Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: evidence that excision of the native heart contributes to post-transplant hypertension.
Taegtmeyer AB; Crook AM; Barton PJ; Banner NR
J Am Coll Cardiol; 2004 Sep; 44(6):1254-60. PubMed ID: 15364328
[TBL] [Abstract][Full Text] [Related]
30. Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients.
Krmar RT; Ferraris JR; Ramirez JA; Sorroche P; Legal S; Cayssials A
Pediatr Nephrol; 2002 Jul; 17(7):540-3. PubMed ID: 12172771
[TBL] [Abstract][Full Text] [Related]
31. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
32. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y
Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758
[TBL] [Abstract][Full Text] [Related]
33. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
34. [Antihypertensive effect and safety evaluation of vegetable drink with peptides derived from sardine protein hydrolysates on mild hypertensive, high-normal and normal blood pressure subjects].
Kawasaki T; Jun CJ; Fukushima Y; Kegai K; Seki E; Osajima K; Itoh K; Matsui T; Matsumoto K
Fukuoka Igaku Zasshi; 2002 Oct; 93(10):208-18. PubMed ID: 12471719
[TBL] [Abstract][Full Text] [Related]
35. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
36. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study.
Wang X; Li W; Li N; Li J
JPEN J Parenter Enteral Nutr; 2008; 32(3):236-41. PubMed ID: 18443134
[TBL] [Abstract][Full Text] [Related]
38. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
39. The antiproteinuric effect of losartan is systemic blood pressure dependent.
Crowe AV; Howse M; Vinjamuri S; Kemp GJ; Williams PS
Nephrol Dial Transplant; 2003 Oct; 18(10):2160-4. PubMed ID: 13679496
[TBL] [Abstract][Full Text] [Related]
40. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
